ReviewMethods in molecular biology (Clifton, N.J.)2025
Inositol Phosphate Kinase Architecture: Practical Approaches and Lessons Learned.
Review in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inositol phosphate and pyrophosphate kinases (InsPKs) regulate cellular signaling by phosphorylating inositol phosphates, which play key roles in diverse physiological processes from insulin signaling to cell proliferation. Here, we review the structural biology of these enzymes and our understanding of their distinctive architectures. InsPKs can be classified into two structural families, which consist of InsPKs and other enzymes: the protein kinase-like and ATP-Grasp, each with distinct catalytic features. While crystal structures have been determined for representative catalytic domains through the InsPK synthetic pathways, structural information remains limited to these domains, with little information to guide our understanding of regulatory mechanisms or architectures of multidomain InsPKs. Here, we review the evolution of InsPK classification from early substrate-based naming to modern structural family groupings. We highlight how structural insights have revealed relationships between seemingly unrelated enzymes and what can be understood about InsPKs from features they share with other enzymes. We also provide an overview of the decision points in InsPK structural biology, from protein engineering and expression to crystallization, emphasizing how choices at each stage impact both the likelihood of success and the biological relevance of the results. We discuss the tools and recent advances, such as AlphaFold structure predictions, which have provided new insights into previously intractable regions of InsPKs and offer guidance for future exploration of these kinases.
Indexed as
Identifiers
40879986What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.